Trending Reports

Quick Access to
Research Assistance

We can help you find what you need. Get in touch with us.

Get Alerts!

Receive e-mail alerts on latest market research

Drug Discovery - Global Market Research

Drug Discovery - Global Market Research

Refine Search
Show
per page

Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs

Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs Summary GBI Research, the leading business intelligence provider, has released its latest research, Biomarkers In Drug Discovery - Optimizing Drug Discovery Timeline an....

Drug Discovery | Feb 01st, 2010 | by GBI Research

Industry : Healthcare

Read more

$3,500

Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting

Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting Summary GBI Research, the leading business intelligence provider, has released its latest report, Drug Discovery in India and China - Gaining Momentum....

Drug Discovery | Feb 01st, 2010 | by GBI Research

Industry : Healthcare

Read more

$3,500

GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing

GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing Summary GBI Research, the leading business intelligence provider, has released its latest research GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR ....

Drug Discovery | Nov 01st, 2011 | by GBI Research

Industry : Healthcare

Read more

$3,500

e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies

e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies Summary GBI Research, the leading business intelligence provider, ....

Drug Discovery | Jul 31st, 2012 | by GBI Research

Industry : Healthcare

Read more

$3,500

Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Targets

Epigenetics R&D; Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Targets Summary GBI Research, a leading business intelligence provider, has released its latest research, entitle....

Drug Discovery | Jul 31st, 2012 | by GBI Research

Industry : Healthcare

Read more

$3,500
Show
per page